SUBSCRIBE
SUBSCRIBE
Bio NC

Biocryst Pharmaceuticals to Present at Two Upcoming Investor Conferences

May 31, 2011 | 
1 min read
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced that executives from BioCryst are scheduled to present and provide a corporate summary and update regarding the Company’s clinical programs at the following investor conferences:
Events
BioCryst Pharmaceuticals, Inc.
MORE ON THIS TOPIC
Podcast
Sentiment at BIO soars as FDA resets, dealmaking evolves; Amgen’s Tavneos in hot water
July 1, 2026
 · 
2 min read
 · 
Jef Akst
From left, Anamaria Sudarov, Rachel Lane, Deepa Talpade, Casarine Chong and Chad Diehl.
Mergers & acquisitions
BIO 2026: Forget dual track—biopharma deals are more complex than ever
June 25, 2026
 · 
5 min read
 · 
Annalee Armstrong
People raise their hands. Leadership fights. The concept of fighting for rights. Revolution or protest. vector
Pancreatic cancer
Revolution’s second RAS blocker doubles chemo response rate in pancreatic cancer
June 25, 2026
 · 
2 min read
 · 
Tristan Manalac
From left to right: Lowell Zeta, acting chief of staff and deputy commissioner; Karim Mikhail, acting CBER director; Michael Davis, acting CDER director; John Crowley, president and CEO of BIO
Policy
FDA hiring 2,200 people to staff up after last year’s DOGE cuts
June 24, 2026
 · 
3 min read
 · 
Jef Akst